Question · asked by 1 review
Bowman-Birk inhibitor vs placebo or no treatment: Improvement of histological features (not improved)
- Population
- People with a diagnosis of oral leukoplakia
- Intervention
- Bowman-Birk inhibitor
- Comparison
- placebo or no treatment
- Outcome
- Improvement of histological features (not improved)
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Bowman-Birk inhibitor vs Placebo or no treatment Improvement of histological features (not improved) · People with a diagnosis of oral leukoplakia Interventions for treating oral leukoplakia to prevent oral cancer (2016) · Cochrane All outcomes | SoF 6, Histological changes: 'Not measured'. Effects text: data on histological changes from Armstrong 2013 were not available for analysis, but study authors reported no statistically significant differences in… | 1 study | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for treating oral leukoplakia to prevent oral cancer 2016 · Cochrane All outcomes | 2016-05 | Not listed | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.